Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

European Journal of Cancer

Volumn 29, Issue 3, 1993, Pages 319-324

  Trillet Lenoir, V ^a   Green, J ^b   Manegold, C ^c   Von Pawel, J ^d   Gatzemeier, U ^e   Lebeau, B ^g   Depierre, A ^f   Johnson, P ^h   Decoster, G ⁱ   Tomita, D ^k   Ewen, C ^j  

^a LOUIS PRADEL HOSPITAL   (France)

^b CLATTERBRIDGE HOSPITAL   (United Kingdom)

^c Thoraxklinik der LVA   (Germany)

^d ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^e KRANKENHAUS GROSSHANSDORF   (Germany)

^f HÔPITAL SAINT JACQUES   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

ⁱ F HOFFMANN LA ROCHE LTD   (Switzerland)

^j AMGEN LTD   (United Kingdom)

^k AMGEN INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; CARCINOMA, SMALL CELL; CYCLOPHOSPHAMIDE; DOUBLE-BLIND METHOD; DOXORUBICIN; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; NEUTROPENIA; RECOMBINANT PROTEINS;

EID: 0027390482     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(93)90376-Q     Document Type: Article

References (16)

1. Chemotherapy in small cell lung cancer: A consensus report
2. Infections in the cancer patient
3. Quantitative relationships between circulating leukocytes and infection in patients with acute leukaemia
4. Management of hematologic and infectious complications of intensive induction therapy for small cell carcinoma of the lung
5. Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy
6. Therapy of small cell lung cancer: A perspective on two decades of clinical research
7. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy
8. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer
9. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
10. Nonparametric Estimation from Incomplete Observations
11. Average relative dose intensity and the impact on design of clinical trials
12. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of non-hematopoietic tumour cells
13. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer
14. Fever in paediatric and young adult patients with cancer
15. Empirical antibiotic therapy for febrile granulocytopenic cancer patients; lessons from four EORTC trials
16. Dose-intensity meta-analysis of chemotherapy regimens in small cell carcinoma of the lung